Outcome of the Board Meeting held today i.e. November 14, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Eraaya Lifespaces deferred its Q2 and H1 FY26 (ended September 30, 2025) unaudited financial results to the next meeting, citing the need to verify certain transactions, valuations, and business reorganisations within its subsidiaries. The Board approved a preferential allotment of 28,60,412 equity shares at Rs. 40.64 per share (face value Re. 1, premium Rs. 39.64) to two non-promoter investors — Melanie Lane Partners Series Fund LLP (16,50,172 shares) and Watch Hill Capital (12,10,240 shares). These shares are being issued in lieu of the allottees' existing shareholding in Ebix Inc., a subsidiary, along with certain other obligations. After this allotment, Eraaya Lifespaces will own 100% of Ebix Inc., eliminating any minority interest. Promoter holding will dilute from 35.61% to about 26.95% on a fully diluted basis. An EGM has been scheduled for December 9, 2025, to seek shareholder approval for the preferential issue.
Shareholders should note that Q2 results have been delayed due to ongoing verification of subsidiary-related transactions, which may create uncertainty in the near term. The preferential allotment will significantly dilute promoter stake and consolidate Ebix Inc. fully under the company, but its impact on shareholder value depends on the final issue price and the value of Ebix Inc. relative to the consideration paid.